The pending sale of Madison’s Cellular Dynamics International Inc. should end the company’s nagging financial struggles and could prove to be the moment that stem cell technology came of age, emerging from a blurry vision to a period of concrete medical advances — including the laboratory production of working human organs. Read the full Milwaukee Journal Sentinel story here.
- Milwaukee Business Journal: Half a billion dollars in VC funds to converge on Madison to hear state startups pitchSeptember 20, 2019
- InsideWis: Turning early stage rejection into ‘yes’ can depend on supply of cashSeptember 19, 2019
- Recovering from business loss is ex-NFL player’s topic Nov. 6 during Early Stage SymposiumSeptember 18, 2019
- Release: WARF investment fund signals new tack in effort to grow adoption of UW–Madison technologiesSeptember 17, 2019
- Investors will meet with emerging companies at 2019 Wisconsin Early Stage SymposiumSeptember 16, 2019